MCID: AZS001
MIFTS: 47

Azoospermia

Categories: Reproductive diseases

Aliases & Classifications for Azoospermia

MalaCards integrated aliases for Azoospermia:

Name: Azoospermia 12 37 29 55 6 44 15 73
Spermatogenic Failure 12 37 6
Spermatogenic Failure, Susceptibility to 6

Classifications:



External Ids:

Disease Ontology 12 DOID:14227
ICD10 33 N46.0 N46.01
ICD9CM 35 606.0
MeSH 44 D053713
NCIt 50 C80076
SNOMED-CT 68 48188009
UMLS 73 C0004509

Summaries for Azoospermia

Disease Ontology : 12 A male infertility disease characterized by the absence of any measurable level of sperm in semen.

MalaCards based summary : Azoospermia, also known as spermatogenic failure, is related to spermatogenic failure 4 and spermatogenic failure, y-linked, 2. An important gene associated with Azoospermia is DAZL (Deleted In Azoospermia Like). The drugs Metformin and Estradiol have been mentioned in the context of this disorder. Affiliated tissues include testis, testes and liver, and related phenotypes are endocrine/exocrine gland and reproductive system

Wikipedia : 76 Azoospermia is the medical condition of a man whose semen contains no sperm. It is associated with... more...

Related Diseases for Azoospermia

Diseases related to Azoospermia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 132)
# Related Disease Score Top Affiliating Genes
1 spermatogenic failure 4 33.0 AR SYCP3
2 spermatogenic failure, y-linked, 2 32.2 DAZ1 DAZ2 DAZ3 DAZ4 DDX3Y RBMY1A1
3 spermatogenic failure, x-linked, 1 31.8 DAZ1 DAZ4 DAZL DDX3Y RBMY1A1 USP9Y
4 oligospermia 30.9 AR DAZ1 DAZ4
5 infertility 30.1 DAZ1 DAZ4 DAZL DDX3Y FSHB TEX15
6 oligoasthenoteratozoospermia 30.1 AR DAZL
7 cryptorchidism, unilateral or bilateral 30.0 AR AZF1 DAZ1
8 male infertility 29.6 AR BOLL DAZ1 DAZ2 DAZ3 DAZ4
9 spermatogenic failure 10 12.6
10 spermatogenic failure 9 12.5
11 spermatogenic failure 6 12.5
12 spermatogenic failure 11 12.5
13 spermatogenic failure 16 12.5
14 spermatogenic failure 5 12.5
15 spermatogenic failure 19 12.5
16 spermatogenic failure 20 12.5
17 spermatogenic failure 21 12.5
18 spermatogenic failure 7 12.5
19 spermatogenic failure 18 12.5
20 morbid obesity and spermatogenic failure 12.5
21 spermatogenic failure 17 12.5
22 spermatogenic failure 24 12.4
23 spermatogenic failure 26 12.4
24 spermatogenic failure 27 12.4
25 spermatogenic failure 1 12.4
26 spermatogenic failure 31 12.4
27 spermatogenic failure 33 12.4
28 spermatogenic failure 34 12.4
29 spermatogenic failure, y-linked, 1 12.2
30 y chromosome infertility 11.9
31 young syndrome 11.8
32 spinocerebellar ataxia 32 11.6
33 macrozoospermia 11.3
34 vas deferens, congenital bilateral aplasia of 11.2
35 spermatogenic failure 15 11.1
36 spermatogenic failure 22 11.1
37 spermatogenic failure 23 11.1
38 vas deferens, congenital bilateral aplasia of, x-linked 11.1
39 spermatogenic failure, x-linked, 2 11.1
40 spermatogenic failure 12 11.1
41 spermatogenic failure 13 11.1
42 spermatogenic failure 14 11.1
43 spermatogenic failure 25 11.1
44 spermatogenic failure 3 11.0
45 spermatogenic failure 2 10.9
46 hypogonadotropic hypogonadism 24 without anosmia 10.9
47 androgen insensitivity, partial 10.9
48 46,xx sex reversal 1 10.9
49 leukoencephalopathy with dystonia and motor neuropathy 10.9
50 spermatogenic failure 8 10.9

Comorbidity relations with Azoospermia via Phenotypic Disease Network (PDN):


Prostate Cancer

Graphical network of the top 20 diseases related to Azoospermia:



Diseases related to Azoospermia

Symptoms & Phenotypes for Azoospermia

MGI Mouse Phenotypes related to Azoospermia:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.56 AR BOLL DAZ2 FKBP6 FSHB SOHLH1
2 reproductive system MP:0005389 9.23 AR BOLL DAZ2 FKBP6 FSHB SOHLH1

Drugs & Therapeutics for Azoospermia

Drugs for Azoospermia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 83)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Metformin Approved Phase 4 657-24-9 14219 4091
2
Estradiol Approved, Investigational, Vet_approved Phase 4,Not Applicable 50-28-2 5757
3 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Not Applicable 979-32-8
4
Polyestradiol phosphate Approved Phase 4,Not Applicable 28014-46-2
5
Testosterone enanthate Approved Phase 4,Phase 2,Phase 3,Phase 1 315-37-7 9416
6
Methyltestosterone Approved Phase 4,Phase 2,Phase 3,Phase 1 58-18-4 6010
7
Testosterone undecanoate Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 5949-44-0
8
Testosterone Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 58-22-0 6013
9
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Not Applicable 77-92-9 311
10
Ginseng Approved, Investigational, Nutraceutical Phase 4 50647-08-0
11
Enclomiphene Investigational Phase 4,Phase 3,Not Applicable 15690-57-0
12 Citrate Phase 4,Phase 3,Not Applicable
13 Clomiphene Phase 4,Phase 3,Not Applicable
14 insulin Phase 4,Not Applicable
15 Estrogen Antagonists Phase 4,Phase 3,Not Applicable
16 Chorionic Gonadotropin Phase 4,Phase 2
17 Zuclomiphene Phase 4,Phase 3,Not Applicable
18 Estrogen Receptor Antagonists Phase 4,Phase 3,Not Applicable
19 Estrogen Receptor Modulators Phase 4,Phase 3,Not Applicable
20 Fertility Agents Phase 4,Phase 3,Not Applicable
21 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
22 Selective Estrogen Receptor Modulators Phase 4,Phase 3,Not Applicable
23 Anticoagulants Phase 4,Phase 3,Not Applicable
24 Estrogens Phase 4,Phase 3,Not Applicable
25 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
26 Insulin, Globin Zinc Phase 4,Not Applicable
27 Hypoglycemic Agents Phase 4,Not Applicable
28 Calcium, Dietary Phase 4,Phase 3,Not Applicable
29 Chelating Agents Phase 4,Phase 3,Not Applicable
30 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
31 Follicle Stimulating Hormone Phase 4,Phase 3
32 Antineoplastic Agents, Hormonal Phase 4,Phase 2,Phase 3,Phase 1
33 Estradiol 3-benzoate Phase 4,Not Applicable
34 Androgens Phase 4,Phase 2,Phase 3,Phase 1
35 Estradiol 17 beta-cypionate Phase 4,Not Applicable
36 Testosterone 17 beta-cypionate Phase 4,Phase 2,Phase 3,Phase 1
37 Anabolic Agents Phase 4,Phase 2,Phase 3,Phase 1
38
Letrozole Approved, Investigational Phase 3 112809-51-5 3902
39
Castor oil Approved, Investigational, Nutraceutical, Vet_approved Phase 2, Phase 3 8001-79-4
40 Aromatase Inhibitors Phase 3
41 Steroid Synthesis Inhibitors Phase 3
42 Castor Phase 2, Phase 3
43 Cathartics Phase 2, Phase 3
44 Laxatives Phase 2, Phase 3
45 Gastrointestinal Agents Phase 2, Phase 3
46
Goserelin Approved Phase 2 65807-02-5 47725 5311128
47
Isotretinoin Approved Phase 2 4759-48-2 5538 5282379
48
Tretinoin Approved, Investigational, Nutraceutical Phase 2 302-79-4 5538 444795
49 Contraceptive Agents Phase 2,Phase 1
50 Keratolytic Agents Phase 2

Interventional clinical trials:

(show top 50) (show all 55)
# Name Status NCT ID Phase Drugs
1 Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH Unknown status NCT02307994 Phase 4 75IU uFSH
2 Metformin for the Treatment of Unexplained Oligozspermia Unknown status NCT01529177 Phase 4 Metformin / clomid / hCG;Clomiphene citrate / hCG
3 Effects of Korean Red Ginseng on Semen Parameters in Male Infertility Patients: a Randomized, Placebo-controlled, Double-blind Clinical Study Completed NCT02204826 Phase 4 Korean Red Ginseng (KRG)
4 Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters Recruiting NCT03203681 Phase 4 NATESTO® (4.5% nasal testosterone) Nasal Gel
5 FSH Treatment for Non-obstructive Azoospermic Patients Unknown status NCT02275169 Phase 3 Urofollitropin
6 Effect of Letrozole on Seminal Parameters in Men With Non Obstructive Azoospermia and Severe Oligozoospermia. Completed NCT02900105 Phase 3 Letrozole
7 The Comparison of Diagnostic TESE and TESA in Non-obstructive Azoospermic Completed NCT01210326 Phase 2, Phase 3
8 Androgen for Leydig Cell Proliferation Completed NCT01206270 Phase 2, Phase 3 Testosterone undecanoate;Castor Oil
9 Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm Cells Not yet recruiting NCT03615547 Phase 3 Clomifene Citrate
10 GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia Unknown status NCT02544191 Phase 2 GnRHa/ hCG/ hMG
11 Testicular Injection of Autologous Stem Cells for Treatment of Patients With Azoospermia Unknown status NCT02041910 Phase 1, Phase 2
12 MSCs For Treatment of Azoospermic Patients Unknown status NCT02025270 Phase 1, Phase 2
13 RA-4: 13-cis Retinoic Acid for Treatment of Men With Azoospermia Recruiting NCT03323801 Phase 2 13-cis retinoic acid
14 Intra-Testicular Transplantation of Autologous Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility. Recruiting NCT02641769 Phase 1, Phase 2
15 Autologous Adipose-Derived Adult Stromal Vascular Cell Administration for Male Patients With Infertility Enrolling by invitation NCT03762967 Phase 2 Standard therapy.
16 Contraception in Normal and Subnormal Men Terminated NCT00167141 Phase 2 injection of hormonal male contraceptive
17 Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men Completed NCT00891228 Phase 1 Testosterone;Nestorone®;Nestorone®;Nestorone®
18 Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia Unknown status NCT02008799 Not Applicable
19 Use of Semen TEX101 to Improve Sperm Retrieval Rates for Men With Non-obstructive Azoospermia Unknown status NCT02851966 Not Applicable
20 Outcome of ICSI Using Cryopreserved Testicular Sperm From Infertile Men With Varicocele-associated Azoospermia Unknown status NCT02306499 Not Applicable
21 Spermatogonial Stem Cells in Azoospermic Patients: a Comparison Between Obstructive and Non-obstructive Azoospermia Unknown status NCT01178463
22 The Effect of Low Electrical Current on Testicular Spermatocyte Count Unknown status NCT02617173 Not Applicable
23 Trial to Evaluate Erectile Function, Fertility and Sperm Count in Male Cyclists Compared to Age Matched Controls Unknown status NCT00282477
24 Modern Analyses of the Semen in Evaluating Male Fertility and Treatment Options of Male Infertility Unknown status NCT02932865
25 Isolation of the Spermatic Cord in Mesh Inguinal Hernia Repair Unknown status NCT01391455 Not Applicable
26 A Preliminary Study on Effect of Omega-3 on Human Sperm Unknown status NCT00479960 Early Phase 1
27 Estradiol and Testosterone Levels in Seminal Plasma of Men With Non-obstructive Azoospermia Completed NCT02255396
28 Insulin Resistance in Idiopathic Oligospermia and Azoospermia Completed NCT01509482 Not Applicable
29 Microdissection Testicular Sperm Extraction (MicroTESE) and IVF-ICSI Outcome in Non-Obstructive Azoospermia (NOA) Completed NCT00484081 Not Applicable
30 The Acceptance, Safety, and Efficacy of MadaJet Versus Needle Injection for Sperm Retrieval in Patients With Azoospermia Completed NCT03181243 Not Applicable
31 Study of Synapsis and Recombination in Male Meiosis and the Implications in Infertility Completed NCT02339272
32 Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection Completed NCT02414295 Not Applicable Mesenchymal stem cell injection
33 HPV as a Possible Cause of Azoospermia Completed NCT02329275
34 Obtaining Undifferentiated Cells From Testis Biopsy Completed NCT01375062 Not Applicable
35 Genetic Studies Spermatogenic Failure Completed NCT00548977
36 Chromosomal and Morphological Structure of Mature and Immature Male Germ Cells and Recognition of IL-18 in Testicular Tissue of Azoospermic Men Completed NCT00544089
37 Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients Completed NCT01150318 Not Applicable Administration of 131 iodine
38 Role of the Toxic Metal Cadmium in the Mechanism Producing Infertility With a Varicocele Completed NCT00044369
39 Detection of Microdeletions in the Azoospermia Factor (AZF) Regions in Infertile Male Patients Recruiting NCT03497728
40 Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT Recruiting NCT02043444 Not Applicable
41 Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism Recruiting NCT02137265 Not Applicable Clomiphene;Placebo
42 Retrieval of Sperm From Men With Azoospermia Using Ultrasound-guided Rete Testis Aspiration Recruiting NCT03291522
43 Surgical Sperm Retrieval in Non-obstructive Azoospermic Men: mTESE vs. TESA Recruiting NCT03550716 Not Applicable
44 The Potential of Sperm Retrieved by Micro-TESE to Fertilize Vitrified/Warmed Oocytes Recruiting NCT03809026
45 Treatment of Severe Male Infertility - Predictive Factors (Imaging) Recruiting NCT02931721
46 Reproductive Capacity and Iron Burden in Thalassemia Recruiting NCT02308904 Not Applicable
47 Treatment of Intrauterine Adhesions and Its Distribution of Genital Tract Flora Recruiting NCT03731689 Not Applicable Intrauterine lavage therapy;Intrauterine gel-injection therapy
48 Comparison of Medical Results of Testicular Sperm Extraction by Conventional Surgery and Microsurgical Track Active, not recruiting NCT02773498 Not Applicable
49 Fertility Preservation in Cases of Klinefelter Syndrome. Active, not recruiting NCT01918280 Not Applicable
50 Quantitative MRI for Functional Imaging of the Testis: A New Methodology for Evaluation of the Infertile Male Enrolling by invitation NCT02756325 Not Applicable

Search NIH Clinical Center for Azoospermia

Cochrane evidence based reviews: azoospermia

Genetic Tests for Azoospermia

Genetic tests related to Azoospermia:

# Genetic test Affiliating Genes
1 Azoospermia 29

Anatomical Context for Azoospermia

MalaCards organs/tissues related to Azoospermia:

41
Testis, Testes, Liver, Prostate, Kidney, Spinal Cord, Brain

Publications for Azoospermia

Articles related to Azoospermia:

(show top 50) (show all 1191)
# Title Authors Year
1
Predictive factors of successful salvage microdissection testicular sperm extraction (mTESE) after failed mTESE in patients with non-obstructive azoospermia: Long-term experience at a single institute. ( 29974724 )
2018
2
Diffusion tensor imaging parameters in testes with nonobstructive azoospermia. ( 29659092 )
2018
3
Exosomal microRNAs in seminal plasma are markers of the origin of azoospermia and can predict the presence of sperm in testicular tissue. ( 29635626 )
2018
4
Sperm retrieval rate and reproductive outcome of infertile men with azoospermia factor c deletion. ( 29920741 )
2018
5
Assessment of the use of contrast enhanced ultrasound in guiding microdissection testicular sperm extraction in nonobstructive azoospermia. ( 29792185 )
2018
6
Investigation of piwi-interacting RNA pathway genes role in idiopathic non-obstructive azoospermia. ( 29317647 )
2018
7
Successful onco-testicular sperm extraction from a testicular cancer patient with a single testis and azoospermia. ( 29662825 )
2018
8
Clinical comparison between conventional and microdissection testicular sperm extraction for non-obstructive azoospermia: Understanding which treatment works for which patient. ( 29974723 )
2018
9
Usefulness of Testicular Volume, Apparent Diffusion Coefficient, and Normalized Apparent Diffusion Coefficient in the MRI Evaluation of Infertile Men With Azoospermia. ( 29364721 )
2018
10
Re: Fertility Outcomes after Extended Searches for Ejaculated Spermatozoa in Men with Virtual Azoospermia. ( 29642333 )
2018
11
Do body mass index, hormone profile and testicular volume effect sperm retrieval rates of microsurgical sperm extraction in the patients with nonobstructive azoospermia? ( 29733793 )
2018
12
Heterogenicity of testicular histopathology and tubules as a predictor of successful microdissection testicular sperm extraction in men with nonobstructive azoospermia. ( 29851822 )
2018
13
Azoospermia and embryo morphokinetics: testicular sperm-derived embryos exhibit delays in early cell cycle events and increased arrest prior to compaction. ( 29785530 )
2018
14
From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia. ( 29904161 )
2018
15
An Association Study between Longitudinal Changes of Leukocyte Telomere and the Risk of Azoospermia in a Population of Iranian Infertile Men ( 29704891 )
2018
16
Association of rs1057035polymorphism in microRNA biogenesis pathway gene (DICER1) with azoospermia among Iranian population. ( 29892896 )
2018
17
Relevance of testicular histopathology on prediction of sperm retrieval rates in case of non-obstructive and obstructive azoospermia. ( 29846141 )
2018
18
Analysis of CDK2 mutations in Chinese men with non-obstructive azoospermia who underwent testis biopsy. ( 29373224 )
2018
19
Comparison of intracytoplasmic sperm injection outcome with fresh versus frozen-thawed testicular sperm in men with nonobstructive azoospermia: a systematic review and meta-analysis. ( 29785532 )
2018
20
Re: Fertility Outcomes After Extended Searches for Ejaculated Spermatozoa in Men with Virtual Azoospermia. ( 29162350 )
2018
21
ADAMTS1 and ADAMTS5 metalloproteases produced by Sertoli cells: a potential diagnostic marker in azoospermia. ( 29737873 )
2018
22
Microdissection testicular sperm extraction (micro-TESE): Predictive value of preoperative hormonal levels and pathology in non-obstructive azoospermia. ( 29413225 )
2018
23
Transplantation of Spermatogonial Stem Cells Suspension into Rete Testis of Azoospermia Mouse Model. ( 29250763 )
2018
24
Primary Ovarian Insufficiency and Azoospermia in Carriers of a Homozygous PSMC3IP Stop Gain Mutation. ( 29240891 )
2018
25
Association of the common SNPs in RNF212, STAG3 and RFX2 gene with male infertility with azoospermia in Chinese population. ( 29277047 )
2018
26
Expression analysis of genes encoding TEX11, TEX12, TEX14 and TEX15 in testis tissues of men with non-obstructive azoospermia. ( 29932616 )
2018
27
Surgical management of azoospermia: can the NHS England Clinical Commissioning Policy reduce geographical inequality of services? ( 29105258 )
2018
28
A novel TEX11 mutation induces azoospermia: a case report of infertile brothers and literature review. ( 29661171 )
2018
29
Chromosomal abnormalities in infertile men with azoospermia and severe oligozoospermia in Qatar and their association with sperm retrieval intracytoplasmic sperm injection outcomes. ( 29713544 )
2018
30
Correlation between testicular mast cell count and spermatogenic epithelium in non-obstructive azoospermia. ( 29479754 )
2018
31
Evaluation of seminal plasma proteomics and relevance of FSH in identification of nonobstructive azoospermia: A preliminary study. ( 29528137 )
2018
32
Novel biomarker ZCCHC13 revealed by integrating DNA methylation and mRNA expression data in non-obstructive azoospermia. ( 29531833 )
2018
33
STX2 is a causative gene for nonobstructive azoospermia. ( 29570232 )
2018
34
Seminal plasma miR-192a: a biomarker predicting successful resolution of nonobstructive azoospermia following varicocele repair. ( 29578116 )
2018
35
Successful microdissection testicular sperm extraction for men with non-obstructive azoospermia. ( 29602610 )
2018
36
A Survey of the Common Mutations and IVS8-Tn Polymorphism of Cystic Fibrosis Transmembrane Conductance Regulator Gene in Infertile Men with Nonobstructive Azoospermia and CBAVD in Iranian Population ( 29986553 )
2018
37
Case - Azoospermia with bilateral varicocele and normal folliclestimulating hormone. ( 29989886 )
2018
38
Decreased Expression of CDC25A in Azoospermia as the Etiology of Spermatogenesis Failure. ( 30009144 )
2018
39
Metabolic Fingerprinting of Seminal Plasma from Non-obstructive Azoospermia Patients: Positive Versus Negative Sperm Retrieval. ( 30009145 )
2018
40
XRCC2 mutation causes meiotic arrest, azoospermia and infertility. ( 30042186 )
2018
41
Independent of DAZL-T54A variant and AZF microdeletion in a sample of Egyptian patients with idiopathic non-obstructed azoospermia. ( 30050315 )
2018
42
Bi-allelic Recessive Loss-of-Function Variants in FANCM Cause Non-obstructive Azoospermia. ( 30075111 )
2018
43
Altered miRNA profile in testis of post-cryptorchidopexy patients with non-obstructive azoospermia. ( 30103742 )
2018
44
The role of vasoepididymostomy for treatment of obstructive azoospermia in the era of in vitro fertilization: a systematic review and meta-analysis. ( 30106012 )
2018
45
Severe Congenital Adrenal Hyperplasia Presenting as Bilateral Testicular Tumors and Azoospermia in the Third Decade of Life. ( 30140784 )
2018
46
Non-obstructive azoospermia and shortened leukocyte telomere length: further evidence linking poor health and infertility. ( 30196950 )
2018
47
Shorter leukocyte telomere length is associated with risk of nonobstructive azoospermia. ( 30196961 )
2018
48
Re: Usefulness of Testicular Volume, Apparent Diffusion Coefficient, and Normalized Apparent Diffusion Coefficient in the MRI Evaluation of Infertile Men with Azoospermia. ( 30227557 )
2018
49
Human mitochondrial DNA haplogroup M8a influences the penetrance of m.8684C>T in Han Chinese men with non-obstructive azoospermia. ( 30236824 )
2018
50
Spermatogenesis improved by suppressing the high level of endogenous gonadotropins in idiopathic non-obstructive azoospermia: a case control pilot study. ( 30243299 )
2018

Variations for Azoospermia

ClinVar genetic disease variations for Azoospermia:

6 (show top 50) (show all 98)
# Gene Variation Type Significance SNP ID Assembly Location
1 DAZL NM_001351.3(DAZL): c.160A> G (p.Thr54Ala) single nucleotide variant risk factor rs121918346 GRCh37 Chromosome 3, 16639676: 16639676
2 DAZL NM_001351.3(DAZL): c.160A> G (p.Thr54Ala) single nucleotide variant risk factor rs121918346 GRCh38 Chromosome 3, 16598169: 16598169
3 SPATA16 NM_031955.5(SPATA16): c.1526C> T (p.Ala509Val) single nucleotide variant Uncertain significance rs115095786 GRCh37 Chromosome 3, 172631512: 172631512
4 SPATA16 NM_031955.5(SPATA16): c.1526C> T (p.Ala509Val) single nucleotide variant Uncertain significance rs115095786 GRCh38 Chromosome 3, 172913722: 172913722
5 SPATA16 NM_031955.5(SPATA16): c.1117G> A (p.Asp373Asn) single nucleotide variant Uncertain significance rs763912965 GRCh38 Chromosome 3, 172925457: 172925457
6 SPATA16 NM_031955.5(SPATA16): c.1117G> A (p.Asp373Asn) single nucleotide variant Uncertain significance rs763912965 GRCh37 Chromosome 3, 172643247: 172643247
7 SPATA16 NM_031955.5(SPATA16): c.848+15delA deletion Uncertain significance rs143941722 GRCh38 Chromosome 3, 173019471: 173019471
8 SPATA16 NM_031955.5(SPATA16): c.848+15delA deletion Uncertain significance rs143941722 GRCh37 Chromosome 3, 172737261: 172737261
9 SPATA16 NM_031955.5(SPATA16): c.576C> T (p.Tyr192=) single nucleotide variant Uncertain significance rs146363552 GRCh38 Chromosome 3, 173117156: 173117156
10 SPATA16 NM_031955.5(SPATA16): c.576C> T (p.Tyr192=) single nucleotide variant Uncertain significance rs146363552 GRCh37 Chromosome 3, 172834946: 172834946
11 SPATA16 NM_031955.5(SPATA16): c.105G> A (p.Ala35=) single nucleotide variant Uncertain significance rs141312480 GRCh38 Chromosome 3, 173117627: 173117627
12 SPATA16 NM_031955.5(SPATA16): c.105G> A (p.Ala35=) single nucleotide variant Uncertain significance rs141312480 GRCh37 Chromosome 3, 172835417: 172835417
13 SPATA16 NM_031955.5(SPATA16): c.-121G> A single nucleotide variant Uncertain significance rs189972919 GRCh38 Chromosome 3, 173141205: 173141205
14 SPATA16 NM_031955.5(SPATA16): c.-121G> A single nucleotide variant Uncertain significance rs189972919 GRCh37 Chromosome 3, 172858995: 172858995
15 SPATA16 NM_031955.5(SPATA16): c.-142G> A single nucleotide variant Uncertain significance rs566046620 GRCh38 Chromosome 3, 173141226: 173141226
16 SPATA16 NM_031955.5(SPATA16): c.-142G> A single nucleotide variant Uncertain significance rs566046620 GRCh37 Chromosome 3, 172859016: 172859016
17 SPATA16 NM_031955.5(SPATA16): c.1401G> T (p.Gln467His) single nucleotide variant Uncertain significance rs143774140 GRCh38 Chromosome 3, 172916419: 172916419
18 SPATA16 NM_031955.5(SPATA16): c.1401G> T (p.Gln467His) single nucleotide variant Uncertain significance rs143774140 GRCh37 Chromosome 3, 172634209: 172634209
19 SPATA16 NM_031955.5(SPATA16): c.1143A> G (p.Gln381=) single nucleotide variant Uncertain significance rs73041295 GRCh38 Chromosome 3, 172925431: 172925431
20 SPATA16 NM_031955.5(SPATA16): c.1143A> G (p.Gln381=) single nucleotide variant Uncertain significance rs73041295 GRCh37 Chromosome 3, 172643221: 172643221
21 SPATA16 NM_031955.5(SPATA16): c.440G> A (p.Gly147Glu) single nucleotide variant Likely benign rs16846616 GRCh38 Chromosome 3, 173117292: 173117292
22 SPATA16 NM_031955.5(SPATA16): c.440G> A (p.Gly147Glu) single nucleotide variant Likely benign rs16846616 GRCh37 Chromosome 3, 172835082: 172835082
23 SPATA16 NM_031955.5(SPATA16): c.397A> G (p.Met133Val) single nucleotide variant Benign rs1515442 GRCh38 Chromosome 3, 173117335: 173117335
24 SPATA16 NM_031955.5(SPATA16): c.397A> G (p.Met133Val) single nucleotide variant Benign rs1515442 GRCh37 Chromosome 3, 172835125: 172835125
25 SPATA16 NM_031955.5(SPATA16): c.232G> A (p.Glu78Lys) single nucleotide variant Likely benign rs1515441 GRCh38 Chromosome 3, 173117500: 173117500
26 SPATA16 NM_031955.5(SPATA16): c.232G> A (p.Glu78Lys) single nucleotide variant Likely benign rs1515441 GRCh37 Chromosome 3, 172835290: 172835290
27 SPATA16 NM_031955.5(SPATA16): c.149A> G (p.Asn50Ser) single nucleotide variant Uncertain significance rs16846624 GRCh38 Chromosome 3, 173117583: 173117583
28 SPATA16 NM_031955.5(SPATA16): c.149A> G (p.Asn50Ser) single nucleotide variant Uncertain significance rs16846624 GRCh37 Chromosome 3, 172835373: 172835373
29 SPATA16 NM_031955.5(SPATA16): c.130T> A (p.Ser44Thr) single nucleotide variant Likely benign rs146572379 GRCh38 Chromosome 3, 173117602: 173117602
30 SPATA16 NM_031955.5(SPATA16): c.130T> A (p.Ser44Thr) single nucleotide variant Likely benign rs146572379 GRCh37 Chromosome 3, 172835392: 172835392
31 SPATA16 NM_031955.5(SPATA16): c.104C> T (p.Ala35Val) single nucleotide variant Uncertain significance rs200483368 GRCh38 Chromosome 3, 173117628: 173117628
32 SPATA16 NM_031955.5(SPATA16): c.104C> T (p.Ala35Val) single nucleotide variant Uncertain significance rs200483368 GRCh37 Chromosome 3, 172835418: 172835418
33 SPATA16 NM_031955.5(SPATA16): c.25T> C (p.Leu9=) single nucleotide variant Uncertain significance rs150041488 GRCh38 Chromosome 3, 173117707: 173117707
34 SPATA16 NM_031955.5(SPATA16): c.25T> C (p.Leu9=) single nucleotide variant Uncertain significance rs150041488 GRCh37 Chromosome 3, 172835497: 172835497
35 SPATA16 NM_031955.5(SPATA16): c.1365G> T (p.Val455=) single nucleotide variant Uncertain significance rs199707743 GRCh38 Chromosome 3, 172916455: 172916455
36 SPATA16 NM_031955.5(SPATA16): c.1365G> T (p.Val455=) single nucleotide variant Uncertain significance rs199707743 GRCh37 Chromosome 3, 172634245: 172634245
37 SPATA16 NM_031955.5(SPATA16): c.873G> A (p.Met291Ile) single nucleotide variant Uncertain significance rs368670834 GRCh38 Chromosome 3, 172977028: 172977028
38 SPATA16 NM_031955.5(SPATA16): c.873G> A (p.Met291Ile) single nucleotide variant Uncertain significance rs368670834 GRCh37 Chromosome 3, 172694818: 172694818
39 SPATA16 NM_031955.5(SPATA16): c.828G> A (p.Glu276=) single nucleotide variant Uncertain significance rs776236874 GRCh38 Chromosome 3, 173019506: 173019506
40 SPATA16 NM_031955.5(SPATA16): c.828G> A (p.Glu276=) single nucleotide variant Uncertain significance rs776236874 GRCh37 Chromosome 3, 172737296: 172737296
41 SPATA16 NM_031955.5(SPATA16): c.720G> A (p.Arg240=) single nucleotide variant Likely benign rs55724801 GRCh38 Chromosome 3, 173048987: 173048987
42 SPATA16 NM_031955.5(SPATA16): c.720G> A (p.Arg240=) single nucleotide variant Likely benign rs55724801 GRCh37 Chromosome 3, 172766777: 172766777
43 SPATA16 NM_031955.5(SPATA16): c.546T> C (p.Asp182=) single nucleotide variant Uncertain significance rs886058187 GRCh38 Chromosome 3, 173117186: 173117186
44 SPATA16 NM_031955.5(SPATA16): c.546T> C (p.Asp182=) single nucleotide variant Uncertain significance rs886058187 GRCh37 Chromosome 3, 172834976: 172834976
45 SPATA16 NM_031955.5(SPATA16): c.430A> C (p.Met144Leu) single nucleotide variant Uncertain significance rs140920981 GRCh38 Chromosome 3, 173117302: 173117302
46 SPATA16 NM_031955.5(SPATA16): c.430A> C (p.Met144Leu) single nucleotide variant Uncertain significance rs140920981 GRCh37 Chromosome 3, 172835092: 172835092
47 SPATA16 NM_031955.5(SPATA16): c.91A> T (p.Met31Leu) single nucleotide variant Uncertain significance rs200087565 GRCh38 Chromosome 3, 173117641: 173117641
48 SPATA16 NM_031955.5(SPATA16): c.91A> T (p.Met31Leu) single nucleotide variant Uncertain significance rs200087565 GRCh37 Chromosome 3, 172835431: 172835431
49 SPATA16 NM_031955.5(SPATA16): c.-141C> T single nucleotide variant Uncertain significance rs886058188 GRCh38 Chromosome 3, 173141225: 173141225
50 SPATA16 NM_031955.5(SPATA16): c.-141C> T single nucleotide variant Uncertain significance rs886058188 GRCh37 Chromosome 3, 172859015: 172859015

Copy number variations for Azoospermia from CNVD:

7 (show all 15)
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 218759 7 116907252 117095954 Genomic rearrangement CFTR Azoospermia
2 266752 Y 1 57772954 Microdeletion Azoospermia
3 266760 Y 1 57772954 Microdeletions Azoospermia
4 266846 Y 11300000 57772954 Microdeletio Azoospermia
5 266849 Y 11300000 57772954 Microdeletion Azoospermia
6 266862 Y 11300000 57772954 Microdeletion DAZ Azoospermia
7 266959 Y 174481503 174538309 Deletion AZF Spermatogenic Failure
8 266963 Y 174481503 174538309 Microdeletion AZF Azoospermia
9 266968 Y 174481503 174538309 Microdeletion AZFA Azoospermia
10 266969 Y 174481503 174538309 Microdeletion AZFA Azoospermia
11 267104 Y 23539797 25607639 Deletion BPY2 Azoospermia
12 267118 Y 23684889 23754627 Deletion DAZ Azoospermia
13 267153 Y 24600763 26180436 Deletion CDY1 Azoospermia
14 267157 Y 24738968 26042240 Deletion CSPG4LY Azoospermia
15 267158 Y 24765501 26015710 Deletion GOLGA2LY Azoospermia

Expression for Azoospermia

Search GEO for disease gene expression data for Azoospermia.

Pathways for Azoospermia

GO Terms for Azoospermia

Cellular components related to Azoospermia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nucleus GO:0005634 9.97 AR DAZ1 DAZ2 DAZ3 DAZ4 DAZAP1
2 cytoplasm GO:0005737 9.8 AR BOLL DAZ1 DAZ2 DAZ3 DAZ4
3 synaptonemal complex GO:0000795 9.26 FKBP6 SYCP3
4 protein-containing complex GO:0032991 9.17 AR DAZ1 DAZ2 DAZ3 DAZ4 DAZAP1

Biological processes related to Azoospermia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell differentiation GO:0030154 9.96 BOLL DAZ1 DAZ2 DAZ3 DAZ4 DAZAP1
2 multicellular organism development GO:0007275 9.92 BOLL DAZ1 DAZ2 DAZ3 DAZ4 DAZAP1
3 meiotic cell cycle GO:0051321 9.67 BOLL FKBP6 SYCP3 TEX15
4 germ cell development GO:0007281 9.63 BOLL DAZ1 DAZ2 DAZ3 DAZ4 DAZL
5 spermatogenesis GO:0007283 9.44 AR BOLL DAZ1 DAZ2 DAZ3 DAZ4
6 positive regulation of translational initiation GO:0045948 9.43 BOLL DAZ1 DAZ2 DAZ3 DAZ4 DAZL

Molecular functions related to Azoospermia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 RNA binding GO:0003723 9.91 BOLL DAZ1 DAZ2 DAZ3 DAZ4 DAZAP1
2 mRNA binding GO:0003729 9.7 BOLL DAZ1 DAZ2 DAZ3 DAZ4 DAZL
3 mRNA 3'-UTR binding GO:0003730 9.5 BOLL DAZ1 DAZ2 DAZ3 DAZ4 DAZAP1
4 translation activator activity GO:0008494 9.1 BOLL DAZ1 DAZ2 DAZ3 DAZ4 DAZL

Sources for Azoospermia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....